ERBB2 and triple-negative breast carcinoma: For example, one study that assessed 3,771 BC patients reported that triple negative breast cancers (TNBCs), as well as HER2-positive (HER2+) breast cancer, were found with a significant increase in disease-free survival when TIL concentrations showed 10% escalation (12).